See What HealthDay Can Do For You
Contact Us

Treatment Tied to Survival Benefit in Complex Bladder Cancer

Medically complex patients with superficial disease have reduced deaths with treatment vs. observation

male patient

WEDNESDAY, Oct. 17, 2018 (HealthDay News) -- Cancer treatment is associated with a clinically meaningful survival benefit in older, medically complex patients with superficial bladder cancer (SBC), according to a study published online Oct. 5 in Cancer.

Tullika Garg, M.D., M.P.H., from Geisinger in Danville, Pa., and colleagues evaluated the association between treatment of SBC and 10-year mortality in 1,800 medically complex patients aged ≥60 years.

Overall, 1,485 patients (82.5 percent) received treatment and 315 patients (17.5 percent) underwent observation. The researchers found that treatment was associated with a 30 percent reduction in death, while having multiple complex conditions (MCC) was associated with a 72 percent increase in death in unweighted multivariable analysis. There was also a survival benefit for treatment in weighted analysis with adjustment (adjusted hazard ratio, 0.66).

"These data provide a foundation for future work aimed at personalizing the treatment guidance of older patients with cancer with MCC," the authors write.

Abstract/Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.